vs

Side-by-side financial comparison of KEWAUNEE SCIENTIFIC CORP (KEQU) and ATRenew Inc. (RERE). Click either name above to swap in a different company.

KEWAUNEE SCIENTIFIC CORP is the larger business by last-quarter revenue ($70.1M vs $43.2M, roughly 1.6× ATRenew Inc.). ATRenew Inc. runs the higher net margin — 16.9% vs 3.5%, a 13.4% gap on every dollar of revenue.

Kewaunee Scientific Corporation designs, manufactures, and installs specialized laboratory furniture, fume hoods, and integrated laboratory infrastructure solutions. It serves clients across pharmaceutical, biotech, academic research, healthcare, and industrial R&D segments, with core operations in North America and a steadily expanding global customer base.

ATRenew Inc. operates a leading pre-owned consumer electronics transaction and servicing ecosystem primarily in China. Its core services include end-to-end device recycling, professional quality inspection, certified refurbishment, and resale of smartphones, laptops, tablets and other digital products, serving both individual consumers and enterprise clients across domestic and select Southeast Asian markets.

KEQU vs RERE — Head-to-Head

Bigger by revenue
KEQU
KEQU
1.6× larger
KEQU
$70.1M
$43.2M
RERE
Higher net margin
RERE
RERE
13.4% more per $
RERE
16.9%
3.5%
KEQU

Income Statement — Q2 FY2026 vs Q1 FY2023

Metric
KEQU
KEQU
RERE
RERE
Revenue
$70.1M
$43.2M
Net Profit
$2.4M
$7.3M
Gross Margin
28.1%
Operating Margin
5.9%
Net Margin
3.5%
16.9%
Revenue YoY
46.8%
Net Profit YoY
-18.7%
EPS (diluted)
$0.82

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KEQU
KEQU
RERE
RERE
Q4 25
$70.1M
Q3 25
$71.1M
Q2 25
$77.1M
Q1 25
$67.2M
Q4 24
$47.8M
Q3 24
$48.4M
Q2 24
$56.7M
Q1 24
$46.8M
Net Profit
KEQU
KEQU
RERE
RERE
Q4 25
$2.4M
Q3 25
$3.1M
Q2 25
$4.8M
Q1 25
$1.4M
Q4 24
$3.0M
Q3 24
$2.2M
Q2 24
$11.0M
Q1 24
$2.5M
Gross Margin
KEQU
KEQU
RERE
RERE
Q4 25
28.1%
Q3 25
29.4%
Q2 25
31.2%
Q1 25
27.4%
Q4 24
29.2%
Q3 24
25.8%
Q2 24
25.8%
Q1 24
25.7%
Operating Margin
KEQU
KEQU
RERE
RERE
Q4 25
5.9%
Q3 25
6.8%
Q2 25
11.0%
Q1 25
3.3%
Q4 24
9.3%
Q3 24
5.3%
Q2 24
9.8%
Q1 24
8.1%
Net Margin
KEQU
KEQU
RERE
RERE
Q4 25
3.5%
Q3 25
4.3%
Q2 25
6.3%
Q1 25
2.0%
Q4 24
6.3%
Q3 24
4.5%
Q2 24
19.4%
Q1 24
5.4%
EPS (diluted)
KEQU
KEQU
RERE
RERE
Q4 25
$0.82
Q3 25
$1.04
Q2 25
$1.63
Q1 25
$0.45
Q4 24
$1.01
Q3 24
$0.74
Q2 24
$3.74
Q1 24
$0.85

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KEQU
KEQU
RERE
RERE
Cash + ST InvestmentsLiquidity on hand
$12.6M
$228.0M
Total DebtLower is stronger
$35.3M
Stockholders' EquityBook value
$69.9M
$557.1M
Total Assets
$189.1M
$722.9M
Debt / EquityLower = less leverage
0.50×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KEQU
KEQU
RERE
RERE
Q4 25
$12.6M
Q3 25
$19.5M
Q2 25
$14.9M
Q1 25
$9.5M
Q4 24
$26.0M
Q3 24
$24.2M
Q2 24
$23.3M
Q1 24
$21.3M
Total Debt
KEQU
KEQU
RERE
RERE
Q4 25
$35.3M
Q3 25
$37.4M
Q2 25
$37.7M
Q1 25
$38.0M
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
KEQU
KEQU
RERE
RERE
Q4 25
$69.9M
Q3 25
$67.1M
Q2 25
$64.5M
Q1 25
$60.8M
Q4 24
$59.3M
Q3 24
$56.0M
Q2 24
$54.8M
Q1 24
$44.1M
Total Assets
KEQU
KEQU
RERE
RERE
Q4 25
$189.1M
Q3 25
$193.5M
Q2 25
$194.7M
Q1 25
$189.1M
Q4 24
$134.5M
Q3 24
$132.0M
Q2 24
$134.8M
Q1 24
$126.3M
Debt / Equity
KEQU
KEQU
RERE
RERE
Q4 25
0.50×
Q3 25
0.56×
Q2 25
0.58×
Q1 25
0.62×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KEQU
KEQU
RERE
RERE
Operating Cash FlowLast quarter
$-4.3M
Free Cash FlowOCF − Capex
$-5.8M
FCF MarginFCF / Revenue
-8.3%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
-1.74×
TTM Free Cash FlowTrailing 4 quarters
$5.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KEQU
KEQU
RERE
RERE
Q4 25
$-4.3M
Q3 25
$5.8M
Q2 25
$9.4M
Q1 25
$-2.3M
Q4 24
$8.4M
Q3 24
$-794.0K
Q2 24
$1.1M
Q1 24
$9.5M
Free Cash Flow
KEQU
KEQU
RERE
RERE
Q4 25
$-5.8M
Q3 25
$5.0M
Q2 25
$8.9M
Q1 25
$-3.0M
Q4 24
$7.8M
Q3 24
$-1.1M
Q2 24
$166.0K
Q1 24
$9.0M
FCF Margin
KEQU
KEQU
RERE
RERE
Q4 25
-8.3%
Q3 25
7.1%
Q2 25
11.5%
Q1 25
-4.4%
Q4 24
16.2%
Q3 24
-2.2%
Q2 24
0.3%
Q1 24
19.3%
Capex Intensity
KEQU
KEQU
RERE
RERE
Q4 25
2.2%
Q3 25
1.1%
Q2 25
0.7%
Q1 25
1.0%
Q4 24
1.4%
Q3 24
0.6%
Q2 24
1.7%
Q1 24
1.0%
Cash Conversion
KEQU
KEQU
RERE
RERE
Q4 25
-1.74×
Q3 25
1.87×
Q2 25
1.94×
Q1 25
-1.67×
Q4 24
2.80×
Q3 24
-0.36×
Q2 24
0.10×
Q1 24
3.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KEQU
KEQU

Transferred Over Time$32.9M47%
Transferred At Point In Time$22.3M32%
Other$14.9M21%

RERE
RERE

Segment breakdown not available.

Related Comparisons